Exploring antidiabetic drug targets as potential disease-modifying agents in osteoarthritisResearch in context

Summary: Background: Osteoarthritis is a leading cause of disability, and disease-modifying osteoarthritis drugs (DMOADs) could represent a pivotal advancement in treatment. Identifying the potential of antidiabetic medications as DMOADs could impact patient care significantly. Methods: We designed...

Full description

Bibliographic Details
Published in:	EBioMedicine
Main Authors:	Kai Fu, Shucheng Si, Xinzhong Jin, Yan Zhang, Vicky Duong, Qianying Cai, Guangyi Li, Win Min Oo, Xianyou Zheng, Cindy G. Boer, Yuqing Zhang, Xiaojuan Wei, Changqing Zhang, Youshui Gao, David J. Hunter
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Osteoarthritis Drug targets Antidiabetic drugs Gene expression Mendelian randomization
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396424003219

Similar Items

Genetically proxied antidiabetic drugs targets and stroke risk
by: Yahui Zhu, et al.
Published: (2023-09-01)

Genetic Variation in Targets of Antidiabetic Drugs and Amyotrophic Lateral Sclerosis Risk
by: Mengxia Wan, et al.
Published: (2024-11-01)

Protective effect of antidiabetic drugs against male infertility: evidence from Mendelian randomization
by: Yuqi Li, et al.
Published: (2025-04-01)

Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study
by: Qing X, et al.
Published: (2024-02-01)

Exploring the regulatory mechanisms of antidiabetic drugs on osteoporosis and Bone mineral density
by: Yu-Long Jing, et al.
Published: (2026-06-01)

Causal association between antidiabetic drugs and erectile dysfunction: evidence from Mendelian randomization
by: Lin Feng, et al.
Published: (2024-08-01)

Genetic association of type 2 diabetes and antidiabetic drug target with skin cancer
by: Juyan Zhao, et al.
Published: (2024-11-01)

Genetically Proxied Antidiabetic Drug Target and Primary Open‐Angle Glaucoma: A Mendelian Randomization Study
by: Kefu Tang, et al.
Published: (2024-10-01)

Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
by: Azeez Taoreed Adegoke, et al.
Published: (2021-08-01)

Cancer biology in diabetes update: Focusing on antidiabetic drugs
by: Emi Kawakita, et al.
Published: (2024-05-01)

Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
by: Yogita Dhas, et al.
Published: (2024-09-01)

Utilization study of antidiabetic agents in a teaching hospital of Sikkim and adherence to current standard treatment guidelines
by: Sushrut Varun Satpathy, et al.
Published: (2016-01-01)

Morpholine, Piperazine, and Piperidine Derivatives as Antidiabetic Agents
by: Darya Zolotareva, et al.
Published: (2024-06-01)

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta‐analysis
by: Kansak Boonpattharatthiti, et al.
Published: (2024-11-01)

The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study
by: Mingyan Ju, et al.
Published: (2024-06-01)

Utilization study on prescribing pattern and rational use of antidiabetic drugs in patients with type 2 diabetes mellitus
by: Shaykhah Ghazi Alharbi, et al.
Published: (2026-01-01)

Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for <i>Trypanosoma cruzi</i> Infection
by: Citlali Vázquez, et al.
Published: (2024-12-01)

Disproportionality analysis of infection associated with antidiabetic drug use patterns
by: Tae Hyeon Kim, et al.
Published: (2025-09-01)

Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization
by: Yue Su, et al.
Published: (2024-05-01)

White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
by: Yixuan Zhao, et al.
Published: (2025-04-01)

Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes
by: Joon Ho Moon, et al.
Published: (2024-06-01)

The Role of Antidiabetic Drugs in Bone Health: Assessing the Risk of Osteoporosis Subtypes and Fractures Using Mendelian Randomization
by: Deng G, et al.
Published: (2025-04-01)

Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
by: Mohamed Nasr, et al.
Published: (2021-08-01)

Effects of antidiabetic drugs on bone metabolism
by: Padilla Apuntate Nuria, et al.
Published: (2024-04-01)

Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review
by: Yu Yang, et al.
Published: (2026-06-01)

Metabolic imbalance and brain tumors: The interlinking metabolic pathways and therapeutic actions of antidiabetic drugs
by: Young-Kook Kim, et al.
Published: (2025-05-01)

Comparative thromboembolic risk and polypharmacy-related drug–drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study
by: Duaa Bafail, et al.
Published: (2026-05-01)

Narrative literature review of antidiabetic drugs’ effect on hyperuricemia: elaborating actual data and mechanisms
by: Zhenyu Liu, et al.
Published: (2024-05-01)

Prevalence of diabetes mellitus and antidiabetic drug utilization in the Eastern Bosnia and Herzegovina: A pilot study
by: Popržen Jelena D., et al.
Published: (2018-01-01)

Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications
by: Roxana-Cristina Dobriceanu, et al.
Published: (2025-04-01)

Assessment of knowledge, attitude, and practices towards the usage of antidiabetic drugs for weight loss among Lebanese population
by: Dima Kreidieh, et al.
Published: (2026-04-01)

Drug–Drug and Drug–Disease Interactions Across Antidiabetic Drug Classes: A Narrative Review and Practical Recommendations
by: Cristina-Elena Zbârcea, et al.
Published: (2026-06-01)

Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients
by: Nova Hasani Furdiyanti, et al.
Published: (2018-02-01)

Pharmacovigilance Study of Antidiabetic Drugs in Diabetes Mellitus Patients in Three Pharmacies in Yogyakarta
by: Qarriy 'Aina Urfiyya, et al.
Published: (2025-03-01)

Drug utilization pattern and cost analysis of antidiabetic drugs among type 2 diabetic patients at a teaching hospital in South India: A prospective observational study
by: Sekar Kavitha, et al.
Published: (2025-07-01)

Decoding the impact of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonist on cardiometabolic health: inflammatory mediators at the focus
by: Fang Cheng, et al.
Published: (2025-05-01)

Adherence to newer second‐line oral antidiabetic drugs among people with type 2 diabetes—A systematic review
by: Nynne Sophie Holdt‐Caspersen, et al.
Published: (2024-04-01)

Prevalence and Factors Associated with Non-Adherence to Antidiabetic Medication Among Patients at Mbarara Regional Referral Hospital, Mbarara, Uganda
by: Faisal K, et al.
Published: (2022-02-01)

Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
by: Belén Picatoste, et al.
Published: (2023-03-01)

Risk of hepatocellular carcinoma in adults exposed to oral antidiabetic drugs: a systematic review
by: Shadman Newaz, et al.
Published: (2025-06-01)